Why did 3869.HK stock drop so sharply today?

The drop reflects thin liquidity and heavy selling: **volume 24,200** vs average **1,122**, relative volume **21.58**. Technical oversold signals and leverage concerns (debt to equity **2.01**) amplified the move.

What is Meyka AI’s price forecast for 3869.HK stock?

Meyka AI's forecast model projects **HK$7.12** for a one-year horizon, implying about **+38.52%** versus today’s **HK$5.14**. Forecasts are model-based projections and not guarantees.

Is 3869.HK stock a buy after the fall?

Meyka AI assigns a **B (HOLD)** grade. The company has strong ROE but high leverage and low liquidity. Buyers should wait for volume-confirmed reversal or improved fundamentals.

What technical levels matter for 3869.HK stock today?

Short-term support lies near the year low **HK$4.30** and Bollinger lower band **HK$5.47**. Key resistance sits near the 50-day average **HK$5.89** and the middle band **HK$6.29**.

HK Stocks

3869.HK stock drops 15.46% to HK$5.14 on 30 Jan 2026: oversold near support

ByDanny Kontos January 30, 2026January 30, 2026

The 3869.HK stock plunged 15.46% intraday to HK$5.14 on 30 Jan 2026, making it one of Hong Kong’s top losers in the health-care group. Trading accelerated to 24,200 shares, about 21.58x the average volume, as sellers hit the day low HK$5.00. Hospital Corporation of China Limited (3869.HK) on the HKSE now trades well below its 50-day average of HK$5.89. We examine drivers, fundamentals, technicals and Meyka AI’s forecast to frame next steps for traders and longer-term investors.